Oncolytics Biotech® Inc. Annou...
The paper covers findings from a U.K. translational clinical trial (REO 013) investigating intravenous administration of REOLYSIN in...
read moreThe paper covers findings from a U.K. translational clinical trial (REO 013) investigating intravenous administration of REOLYSIN in...
read moreScanning the genes of children with inherited brain disorders pinpoints the precise cause more than a quarter of the time, often...
read moreIt is hoped reoviruses can be used to treat cancer, but there were fears they would not work if the immune system could wipe them...
read moreThe paper covers findings from a U.K. translational clinical trial (REO 013) investigating intravenous administration of REOLYSIN in...
read moreThe reovirus holds promise as a possible new way of treating cancer because it not only kill cancer cells directly, but also triggers...
read more